Polpharma Group serves as a top-tier pharmaceutical manufacturer in Europe and a reliable partner for pharmaceutical firms globally. With a wide range of products (Rx, CHC, APIs), expert services, and competencies across the value chain, along with extensive knowledge of local CEE/CIS markets, it provides distinct growth opportunities for B2B partners. Collaborating with Polpharma Group offers access to a supportive environment, guidance from skilled professionals, and cutting-edge resources. The company actively seeks partners across various areas of operation, from product development and production to commercial cooperation. Additionally, Polpharma API, a Poland-based CDMO specializing in active pharmaceutical ingredients (APIs), stands as a significant European API supplier, catering to pharmaceutical companies worldwide. The company is in the process of a $45 million manufacturing expansion, incorporating HPAPI and cryogenic technologies, with investments in a pilot plant and R&D capabilities. Operations are set to expand from mid-2023, with full completion expected by 2026.
Products & Services
Acetazolamide
Country
PolandPharmaceutical Works Polpharma
Country
PolandCity
Starogard Gdański
Address
Pelplińska 19, 83-250
Alendronate Sodium
Alendronate Sodium Hydrate
Country
PolandPharmaceutical Works Polpharma
Country
PolandCity
Starogard Gdański
Address
Pelplińska 19, 83-250
Aniracetam
Sites
POLPHARMA, S.A
Audited
Country
PolandCity
Nowa Dęba
Address
Ulica Tadeusza Śmiśniewicza 2, 39-460
Pharmaceutical Works Polpharma S.A.
Country
PolandCity
Starogard Gdański
Address
Pelplińska 19, 83-250
Platinum
2024 Qualifyze Quality Compliance Rating2024 Qualifyze QCRPolpharma
Audited
Country
PolandCity
Sieradz
Address
Wojska Polskiego 73, 98-200
Pharmaceutical Works Polpharma S.A.
Country
PolandCity
Pomorskie
Pharmaceutical Works Polpharma S.A.
Country
PolandCity
Warszawa